Skip to main content
Top
Published in: Diabetologia 7/2009

Open Access 01-07-2009 | Research Letter

Prevention of diabetes by a hydrolysed casein-based diet in diabetes-prone BioBreeding rats does not involve restoration of the defective natural regulatory T cell function

Authors: J. Visser, J. L. Hillebrands, M. Walther Boer, N. A. Bos, J. Rozing

Published in: Diabetologia | Issue 7/2009

Login to get access

Excerpt

To the Editor: Diabetes-prone (DP)-BioBreeding (BB) rats show reduced natural regulatory T cell (nTreg; CD4+/CD25+/forkhead box P3 [FOXP3]+) levels and function, and spontaneously develop type 1 diabetes from 70 days of age [1, 2]. Adoptive transfers of nTregs from diabetes-resistant (DR)-BB rats to DP-BB rats prevents diabetes in DP-BB rats [3, 4]. Environmental factors such as diet are critical triggers for the development of type 1 diabetes [5]. Using the DP-BB rat model for type 1 diabetes, we and others have shown that a hydrolysed casein (HC)-based diet reduces the incidence of diabetes from 90% to 50%, and delays the mean time of diabetes onset [58]. Reduced dietary diabetogenic triggers, skewing of immune responses and induction of islet neogenesis are thought to be the main mechanisms behind the effects of the HC-based diet [58]. …
Literature
1.
go back to reference Mordes JP, Bortell R, Groen H, Guberski DL, Rossini AA, Greiner D (2001) Autoimmune diabetes mellitus in the BB rat. In: Sima AAF, Shafrir E (eds) Animal models for autoimmune diabetes. Harwood Academic, Amsterdam, pp 1–41 Mordes JP, Bortell R, Groen H, Guberski DL, Rossini AA, Greiner D (2001) Autoimmune diabetes mellitus in the BB rat. In: Sima AAF, Shafrir E (eds) Animal models for autoimmune diabetes. Harwood Academic, Amsterdam, pp 1–41
2.
go back to reference Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S (2005) Impaired post-thymic development of regulatory CD4+ 25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol 174:4081–4089PubMed Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S (2005) Impaired post-thymic development of regulatory CD4+ 25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol 174:4081–4089PubMed
3.
go back to reference Lundsgaard D, Holm TL, Hornum L, Markholst H (2005) In vivo control of diabetogenic T-cells by regulatory CD4+ CD25+ T-cells expressing Foxp3. Diabetes 54:1040–1047PubMedCrossRef Lundsgaard D, Holm TL, Hornum L, Markholst H (2005) In vivo control of diabetogenic T-cells by regulatory CD4+ CD25+ T-cells expressing Foxp3. Diabetes 54:1040–1047PubMedCrossRef
4.
go back to reference Hillebrands JL, Whalen B, Visser JT et al (2006) A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 177:7820–7832PubMed Hillebrands JL, Whalen B, Visser JT et al (2006) A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 177:7820–7832PubMed
5.
go back to reference Lefebvre DE, Powell KL, Strom A, Scott FW (2006) Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 26:175–202PubMedCrossRef Lefebvre DE, Powell KL, Strom A, Scott FW (2006) Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 26:175–202PubMedCrossRef
6.
go back to reference Visser J, Brugman S, Klatter F et al (2003) Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat. Metabolism 52:333–337PubMedCrossRef Visser J, Brugman S, Klatter F et al (2003) Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat. Metabolism 52:333–337PubMedCrossRef
7.
go back to reference Brugman S, Klatter FA, Visser J, Bos NA, Elias D, Rozing J (2004) Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against type 1 diabetes in BB-DP rats. An experimental study. Diabetologia 47:1331–1333PubMedCrossRef Brugman S, Klatter FA, Visser J, Bos NA, Elias D, Rozing J (2004) Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against type 1 diabetes in BB-DP rats. An experimental study. Diabetologia 47:1331–1333PubMedCrossRef
8.
go back to reference Wang GS, Gruber H, Smyth P et al (2000) Hydrolyzed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. J Autoimmun 15:407–416PubMedCrossRef Wang GS, Gruber H, Smyth P et al (2000) Hydrolyzed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. J Autoimmun 15:407–416PubMedCrossRef
Metadata
Title
Prevention of diabetes by a hydrolysed casein-based diet in diabetes-prone BioBreeding rats does not involve restoration of the defective natural regulatory T cell function
Authors
J. Visser
J. L. Hillebrands
M. Walther Boer
N. A. Bos
J. Rozing
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1370-3

Other articles of this Issue 7/2009

Diabetologia 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.